MedPath

The effect of adding Pentoxifylline to common treatments in depression in bipolar patients referred to Khorshid Hospital in 1401

Phase 1
Recruiting
Conditions
Depressive phase of bipolar patients type one and two.
Bipolar disorder, current episode depressed, mild or moderate severity
F31.3
Registration Number
IRCT20201119049445N3
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
86
Inclusion Criteria

Patients with type 1 and 2 bipolar disorder with an age range of 18 to 60 years in the depressive phase
Diagnosis of type 1 and 2 bipolar disorder based on DSM-V criteria by a psychiatrist
Have at least five classes of education

Exclusion Criteria

Existence of psychotic symptoms
Existence of another psychiatric disorder
Existence of hypothyroidism
History of cardiovascular disease
Pregnancy or breastfeeding
Existence of hepatic failure
Peptic ulcer
Take antiplatelet drugs or anticoagulants
Receiving non-steroidal anti-inflammatory drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression score in Bipolar Depression Rating Scale questionnaire. Timepoint: At the beginning of the study, weeks 4 and 8 of the study. Method of measurement: Bipolar Depression Rating Scale questionnaire.
Secondary Outcome Measures
NameTimeMethod
Quality of life score. Timepoint: Before the study, weeks 4 and 8 after the study. Method of measurement: 20-item BDRS questionnaire.
© Copyright 2025. All Rights Reserved by MedPath